Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.

Engström A, Perskvist N, Werngren J, Hoffner SE, Juréen P.

J Antimicrob Chemother. 2011 Jun;66(6):1247-54. doi: 10.1093/jac/dkr109. Epub 2011 Mar 21.

2.

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.

Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L.

Antimicrob Agents Chemother. 2009 Dec;53(12):5064-8. doi: 10.1128/AAC.00851-09. Epub 2009 Sep 14.

3.

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.

Maus CE, Plikaytis BB, Shinnick TM.

Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7.

4.

Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis.

Maus CE, Plikaytis BB, Shinnick TM.

Antimicrob Agents Chemother. 2005 Feb;49(2):571-7.

5.

Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.

Du Q, Dai G, Long Q, Yu X, Dong L, Huang H, Xie J.

Diagn Microbiol Infect Dis. 2013 Oct;77(2):138-42. doi: 10.1016/j.diagmicrobio.2013.06.031. Epub 2013 Aug 12.

PMID:
23948547
6.

Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.

Zhang Z, Liu M, Wang Y, Pang Y, Kam KM, Zhao Y.

Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1959-66. doi: 10.1007/s10096-014-2144-5. Epub 2014 Jun 7.

PMID:
24906439
7.

Real-time PCR for single-nucleotide polymorphism detection in the 16S rRNA gene as an indicator for extensive drug resistance in Mycobacterium tuberculosis.

Blaschitz M, Hasanacevic D, Hufnagl P, Hasenberger P, Pecavar V, Meidlinger L, Konrad M, Allerberger F, Indra A.

J Antimicrob Chemother. 2011 Jun;66(6):1243-6. doi: 10.1093/jac/dkr070. Epub 2011 Mar 8.

8.

Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis.

Sirgel FA, Tait M, Warren RM, Streicher EM, Böttger EC, van Helden PD, Gey van Pittius NC, Coetzee G, Hoosain EY, Chabula-Nxiweni M, Hayes C, Victor TC, Trollip A.

Microb Drug Resist. 2012 Apr;18(2):193-7. doi: 10.1089/mdr.2011.0063. Epub 2011 Jul 6.

PMID:
21732736
9.

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W.

J Clin Microbiol. 2010 May;48(5):1683-9. doi: 10.1128/JCM.01947-09. Epub 2010 Mar 24.

10.

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.

Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC.

PLoS One. 2012;7(3):e33275. doi: 10.1371/journal.pone.0033275. Epub 2012 Mar 29. Review.

11.

Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.

Sowajassatakul A, Prammananan T, Chaiprasert A, Phunpruch S.

BMC Microbiol. 2014 Jun 22;14:165. doi: 10.1186/1471-2180-14-165.

12.

Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs.

Leung KL, Yip CW, Yeung YL, Wong KL, Chan WY, Chan MY, Kam KM.

J Appl Microbiol. 2010 Dec;109(6):2087-94. doi: 10.1111/j.1365-2672.2010.04840.x. Epub 2010 Sep 21.

13.

Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.

Khanna A, Raj VS, Tarai B, Sood R, Pareek PK, Upadhyay DJ, Sharma P, Rattan A, Saini KS, Singh H.

Antimicrob Agents Chemother. 2010 Nov;54(11):4789-93. doi: 10.1128/AAC.00661-10. Epub 2010 Aug 16.

14.

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens.

Hillemann D, Rüsch-Gerdes S, Richter E.

J Clin Microbiol. 2009 Jun;47(6):1767-72. doi: 10.1128/JCM.00081-09. Epub 2009 Apr 22.

15.

Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.

Via LE, Cho SN, Hwang S, Bang H, Park SK, Kang HS, Jeon D, Min SY, Oh T, Kim Y, Kim YM, Rajan V, Wong SY, Shamputa IC, Carroll M, Goldfeder L, Lee SA, Holland SM, Eum S, Lee H, Barry CE 3rd.

J Clin Microbiol. 2010 Feb;48(2):402-11. doi: 10.1128/JCM.01476-09. Epub 2009 Dec 23.

16.

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.

Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE.

Antimicrob Agents Chemother. 2011 May;55(5):2032-41. doi: 10.1128/AAC.01550-10. Epub 2011 Feb 7.

17.

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rüsch-Gerdes S, Niemann S.

Antimicrob Agents Chemother. 2009 Aug;53(8):3353-6. doi: 10.1128/AAC.00050-09. Epub 2009 May 26.

18.

Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.

Engström A, Morcillo N, Imperiale B, Hoffner SE, Juréen P.

J Clin Microbiol. 2012 Jun;50(6):2026-33. doi: 10.1128/JCM.06664-11. Epub 2012 Mar 29.

19.

Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.

Zaunbrecher MA, Sikes RD Jr, Metchock B, Shinnick TM, Posey JE.

Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20004-9. doi: 10.1073/pnas.0907925106. Epub 2009 Nov 11.

20.

Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.

Feng Y, Liu S, Wang Q, Wang L, Tang S, Wang J, Lu W.

PLoS One. 2013;8(2):e55292. doi: 10.1371/journal.pone.0055292. Epub 2013 Feb 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk